ProfileGDS4516 / 217649_at
TitleColorectal cancer: laser microdissected tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 1 stage: 2a stage: 2b stage: 3a stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM537341 GSM537345 GSM537355 GSM537366 GSM537370 GSM537380 GSM537392 GSM537415 GSM537417 GSM537422 GSM537423 GSM537427 GSM537430 GSM537336 GSM537337 GSM537348 GSM537349 GSM537356 GSM537361 GSM537374 GSM537377 GSM537378 GSM537379 GSM537383 GSM537388 GSM537395 GSM537400 GSM537404 GSM537409 GSM537418 GSM537425 GSM537333 GSM537342 GSM537347 GSM537350 GSM537362 GSM537363 GSM537368 GSM537376 GSM537381 GSM537386 GSM537398 GSM537402 GSM537405 GSM537371 GSM537421 GSM537424 GSM537432 GSM537331 GSM537332 GSM537334 GSM537338 GSM537353 GSM537357 GSM537358 GSM537375 GSM537389 GSM537390 GSM537393 GSM537399 GSM537407 GSM537408 GSM537428 GSM537354 GSM537410 GSM537413 GSM537396 GSM537397 GSM537330 GSM537369 GSM537373 GSM537401 GSM537343 GSM537367 GSM537382 GSM537385 GSM537391 GSM537419 GSM537420 GSM537429 GSM537431 GSM537387 GSM537414 GSM537433 GSM537335 GSM537339 GSM537340 GSM537344 GSM537346 GSM537351 GSM537352 GSM537359 GSM537360 GSM537364 GSM537365 GSM537372 GSM537384 GSM537394 GSM537403 GSM537406 GSM537411 GSM537412 GSM537416 GSM537426 31% 18% 39% 34% 50% 46% 31% 42% 37% 39% 36% 52% 39% 12% 36% 29% 25% 27% 32% 41% 28% 34% 29% 31% 51% 35% 43% 21% 22% 39% 34% 29% 47% 22% 26% 31% 12% 32% 28% 43% 55% 36% 41% 31% 10% 31% 35% 40% 37% 46% 32% 36% 50% 8% 31% 28% 47% 36% 36% 40% 38% 33% 33% 31% 38% 37% 35% 50% 32% 34% 52% 34% 31% 18% 24% 30% 36% 21% 31% 65% 39% 40% 33% 29% 46% 34% 27% 31% 34% 40% 32% 28% 31% 49% 33% 21% 41% 44% 29% 32% 29% 14% 31% 34% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM537341patient 115, cancer, LCM [OPG study]4.3914231
GSM537345patient 119, cancer, LCM [OPG study]3.8013818
GSM537355patient 138, cancer, LCM [OPG study]4.8382639
GSM537366patient 154, cancer, LCM [OPG study]4.5460834
GSM537370patient 022, cancer, LCM [OPG study]5.4098550
GSM537380patient 037, cancer, LCM [OPG study]5.1598846
GSM537392patient 077, cancer, LCM [OPG study]4.3661831
GSM537415patient 032, cancer, LCM [OPG study]4.9235142
GSM537417patient 042, cancer, LCM [OPG study]4.8015137
GSM537422patient 059, cancer, LCM [OPG study]4.8110739
GSM537423patient 064, cancer, LCM [OPG study]4.6279436
GSM537427patient 084, cancer, LCM [OPG study]5.5128752
GSM537430patient 090, cancer, LCM [OPG study]4.7860139
GSM537336patient 107, cancer, LCM [OPG study]3.56612
GSM537337patient 108, cancer, LCM [OPG study]4.5514936
GSM537348patient 124, cancer, LCM [OPG study]4.2983829
GSM537349patient 125, cancer, LCM [OPG study]4.1002825
GSM537356patient 139, cancer, LCM [OPG study]4.2240527
GSM537361patient 147, cancer, LCM [OPG study]4.4950332
GSM537374patient 026, cancer, LCM [OPG study]4.944241
GSM537377patient 033, cancer, LCM [OPG study]4.3011928
GSM537378patient 034, cancer, LCM [OPG study]4.4954634
GSM537379patient 036, cancer, LCM [OPG study]4.2926229
GSM537383patient 046, cancer, LCM [OPG study]4.3939531
GSM537388patient 063, cancer, LCM [OPG study]5.5143451
GSM537395patient 082, cancer, LCM [OPG study]4.5596835
GSM537400patient 099, cancer, LCM [OPG study]4.9815143
GSM537404patient 129, cancer, LCM [OPG study]4.0154421
GSM537409patient 141, cancer, LCM [OPG study]3.9300622
GSM537418patient 044, cancer, LCM [OPG study]4.7219639
GSM537425patient 070, cancer, LCM [OPG study]4.5316334
GSM537333patient 102, cancer, LCM [OPG study]4.3197629
GSM537342patient 116, cancer, LCM [OPG study]5.249747
GSM537347patient 123, cancer, LCM [OPG study]4.0367422
GSM537350patient 127, cancer, LCM [OPG study]4.1589126
GSM537362patient 148, cancer, LCM [OPG study]4.3946131
GSM537363patient 150, cancer, LCM [OPG study]3.5900512
GSM537368patient 156, cancer, LCM [OPG study]4.4504232
GSM537376patient 031, cancer, LCM [OPG study]4.2731428
GSM537381patient 038, cancer, LCM [OPG study]5.0081743
GSM537386patient 057, cancer, LCM [OPG study]5.7218555
GSM537398patient 094, cancer, LCM [OPG study]4.6176436
GSM537402patient 109, cancer, LCM [OPG study]4.9176141
GSM537405patient 130, cancer, LCM [OPG study]4.4646231
GSM537371patient 023, cancer, LCM [OPG study]3.483710
GSM537421patient 055, cancer, LCM [OPG study]4.3589631
GSM537424patient 065, cancer, LCM [OPG study]4.579135
GSM537432patient 097, cancer, LCM [OPG study]4.8027740
GSM537331patient 100, cancer, LCM [OPG study]4.6907737
GSM537332patient 101, cancer, LCM [OPG study]5.1671646
GSM537334patient 103, cancer, LCM [OPG study]4.4466532
GSM537338patient 110, cancer, LCM [OPG study]4.6555536
GSM537353patient 135, cancer, LCM [OPG study]5.3573650
GSM537357patient 142, cancer, LCM [OPG study]3.364018
GSM537358patient 143, cancer, LCM [OPG study]4.3600931
GSM537375patient 030, cancer, LCM [OPG study]4.2924528
GSM537389patient 068, cancer, LCM [OPG study]5.1912847
GSM537390patient 072, cancer, LCM [OPG study]4.5983836
GSM537393patient 078, cancer, LCM [OPG study]4.6044436
GSM537399patient 095, cancer, LCM [OPG study]4.8361540
GSM537407patient 133, cancer, LCM [OPG study]4.801538
GSM537408patient 140, cancer, LCM [OPG study]4.4923233
GSM537428patient 086, cancer, LCM [OPG study]4.4912333
GSM537354patient 136, cancer, LCM [OPG study]4.3503931
GSM537410patient 146, cancer, LCM [OPG study]4.7277638
GSM537413patient 027, cancer, LCM [OPG study]4.6313937
GSM537396patient 083, cancer, LCM [OPG study]4.5758435
GSM537397patient 088, cancer, LCM [OPG study]5.412450
GSM537330patient 006, cancer, LCM [OPG study]4.4624932
GSM537369patient 015, cancer, LCM [OPG study]4.4951134
GSM537373patient 025, cancer, LCM [OPG study]5.5191652
GSM537401patient 106, cancer, LCM [OPG study]4.5271634
GSM537343patient 117, cancer, LCM [OPG study]4.3657931
GSM537367patient 155, cancer, LCM [OPG study]3.8383418
GSM537382patient 041, cancer, LCM [OPG study]4.0616324
GSM537385patient 053, cancer, LCM [OPG study]4.3540530
GSM537391patient 073, cancer, LCM [OPG study]4.6254136
GSM537419patient 045, cancer, LCM [OPG study]3.9421221
GSM537420patient 052, cancer, LCM [OPG study]4.4238231
GSM537429patient 089, cancer, LCM [OPG study]6.5086665
GSM537431patient 096, cancer, LCM [OPG study]4.8419439
GSM537387patient 061, cancer, LCM [OPG study]4.808640
GSM537414patient 028, cancer, LCM [OPG study]4.4306433
GSM537433patient 098, cancer, LCM [OPG study]4.308429
GSM537335patient 104, cancer, LCM [OPG study]5.1351146
GSM537339patient 111, cancer, LCM [OPG study]4.4557434
GSM537340patient 113, cancer, LCM [OPG study]4.213127
GSM537344patient 118, cancer, LCM [OPG study]4.3960331
GSM537346patient 011, cancer, LCM [OPG study]4.5218234
GSM537351patient 128, cancer, LCM [OPG study]4.8382640
GSM537352patient 134, cancer, LCM [OPG study]4.3811632
GSM537359patient 144, cancer, LCM [OPG study]4.2772528
GSM537360patient 145, cancer, LCM [OPG study]4.3501231
GSM537364patient 152, cancer, LCM [OPG study]5.3489249
GSM537365patient 153, cancer, LCM [OPG study]4.4692933
GSM537372patient 024, cancer, LCM [OPG study]3.9908821
GSM537384patient 048, cancer, LCM [OPG study]4.9002841
GSM537394patient 081, cancer, LCM [OPG study]5.0763244
GSM537403patient 121, cancer, LCM [OPG study]4.2977629
GSM537406patient 131, cancer, LCM [OPG study]4.4448532
GSM537411patient 149, cancer, LCM [OPG study]4.3878529
GSM537412patient 019, cancer, LCM [OPG study]3.687414
GSM537416patient 035, cancer, LCM [OPG study]4.3295131
GSM537426patient 079, cancer, LCM [OPG study]4.4902534